James P. Allison
詹姆斯·艾利森
PhD
Chair, Department of Immunology; Executive Director, Immunotherapy Platform免疫学系主任；免疫治疗平台执行主任
👥Biography 个人简介
James P. Allison is a Nobel Prize-winning immunologist whose discovery that CTLA-4 acts as an inhibitory checkpoint on T cells transformed cancer therapy. By blocking this brake on the immune system with an antibody (ipilimumab), Allison established the field of immune checkpoint blockade, producing durable remissions in advanced melanoma and catalyzing an entirely new class of cancer treatments. His work at MD Anderson continues to define combination immunotherapy strategies that extend benefit across tumor types.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
CTLA-4 Checkpoint Blockade
Demonstrated that blocking CTLA-4 unleashes anti-tumor T cell responses, leading directly to the development of ipilimumab (Yervoy), the first FDA-approved checkpoint inhibitor.
Immune Checkpoint Concept
Established the paradigm that tumors exploit inhibitory immune pathways, fundamentally reframing cancer treatment from targeting the tumor to empowering the immune system.
Combination Immunotherapy
Pioneered clinical investigation of dual checkpoint blockade (anti-CTLA-4 + anti-PD-1), now standard of care for multiple cancers.
Representative Works 代表性著作
Enhancement of Antitumor Immunity Using CTLA-4 Blocking Antibodies
Science (1996)
Landmark preclinical study showing that CTLA-4 blockade results in tumor rejection, founding the field of checkpoint immunotherapy.
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
New England Journal of Medicine (2010)
Phase III trial establishing ipilimumab survival benefit in advanced melanoma, the first immunotherapy to show an overall survival advantage in a solid tumor.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Ziad Obermeyer
University of California, Berkeley; UC San Francisco
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
关注 詹姆斯·艾利森 的研究动态
Follow James P. Allison's research updates
留下邮箱，当我们发布与 James P. Allison（The University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment